An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib

Clinical trial NCT05887609 · RECRUITING

Trial details

NCT number: NCT05887609
Sponsor: University of Colorado, Denver
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Ovary Cancer Peritoneal Cancer Fallopian Tube Cancer

Start date: 2023-10-03
Primary completion: 2029-01-31
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.